|   [18F]-MK-9470 | |
| Names | |
|---|---|
| Preferred IUPAC name N-[(2S,3S)-3-(3-Cyanophenyl)-4-[4-(2-fluoroethoxy)phenyl]butan-2-yl]-2-methyl-2-(5-methylpyridin-2-yl)oxypropanamide | |
| Identifiers | |
| 
 | |
| 3D model (JSmol) | |
| ChemSpider | |
|  PubChem CID | |
| UNII | 
 | 
|  CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C29H32FN3O3 | |
| Molar mass | 489.591 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
MK-9470 is a synthetic compound which binds to the CB1 cannabinoid receptor and functions as an inverse agonist. The 18F-labeled version, [18F]-MK-9470, is used in research as a positron emission tomography (PET) tracer for brain imaging of the CB1 receptor. [1]